Linked Life Data

2662837

Source:http://linkedlifedata.com/resource/pubmed/id/2662837

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1989-8-8
pubmed:abstractText
We evaluated the effect of oral fenoterol at a daily dosage of 0.25 mg/kg in 17 children with mild bronchial asthma following a double-blind, crossover design. Treatment with fenoterol syrup and matched placebo was given for 4 weeks each and doses administered every six hours. Daily variability of peak expiratory flow rate during fenoterol treatment was not different from that measured during placebo. Fenoterol syrup was associated with a statistically significant improvement in daytime symptom scores, whereas nighttime symptoms were not significantly reduced. Fenoterol significantly reduced the need for supplemental therapy. Adverse effects remained trivial and minimal for all children. This study indicates that fenoterol syrup alone or in combination with inhaled fenoterol may have a role in the maintenance therapy of mild to moderate childhood asthma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0003-4738
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
76-80
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Controlled trial of oral fenoterol in the treatment of childhood asthma.
pubmed:affiliation
Istituto di Clinica Medica, Università Cattolica S. Cuore, Rome, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial